Analyze Diet

Topic:Hemostasis

Hemostasis in horses refers to the physiological process that stops bleeding and maintains blood in a fluid state within the vascular system. It involves a complex interaction between the vascular endothelium, platelets, and the coagulation cascade, which work together to form a stable blood clot following vascular injury. This process is essential for preventing excessive blood loss and ensuring wound healing. Key components of equine hemostasis include coagulation factors, fibrin formation, and platelet aggregation. Understanding the mechanisms and regulation of hemostasis in horses is important for diagnosing and managing bleeding disorders and other related conditions. This page compiles peer-reviewed research studies and scholarly articles that explore the mechanisms, regulation, and clinical implications of hemostasis in equine medicine.
Template bleeding time and thromboxane generation in the horse: effects of three non-steroidal anti-inflammatory drugs.
Equine veterinary journal    July 1, 1985   Volume 17, Issue 4 322-324 doi: 10.1111/j.2042-3306.1985.tb02509.x
Kopp KJ, Moore JN, Byars TD, Brooks P.No abstract available
Deficiency of the contact phase of intrinsic coagulation in a horse.
Journal of the American Veterinary Medical Association    July 1, 1985   Volume 187, Issue 1 71-72 
Ainsworth DM, Dodds WJ, Brown CM.A 16-year-old gelding was examined because of weight loss, inappetence, and intermittent fever of 2 months' duration. Preliminary laboratory findings revealed anemia, hypoproteinemia, thrombocytopenia, and prolongation of the activated partial thromboplastin time. A deficiency or inhibition of coagulation factor XI, factor XII, or high molecular weight kininogen was diagnosed. This defect was not associated with a bleeding diathesis, but should be considered as a cause of prolongation of the activated partial thromboplastin time.
Furosemide: effects on the hemostatic mechanism of resting and exercised standardbred horses.
American journal of veterinary research    December 1, 1984   Volume 45, Issue 12 2603-2606 
Kociba GJ, Bayly WM, Milne DW, Wigton DH, Gabel AA, Muir WW.Two groups of 6 Standardbred horses each were used to study hemostatic functions at rest and after exercise with furosemide or a placebo. One group which was trained was given maximum exercise on the racetrack, and the other, a less-fit group, was given submaximum exercise on the treadmill. There was no difference in furosemide compared to placebo trial results in either group in coagulation screening tests, platelet concentration, or retention of platelets in a glass bead column. Increased fibrinogen concentration and enhanced platelet retention were associated with maximum exercise. Aggregat...
Heparin anticoagulant therapy in equine colic.
Modern veterinary practice    August 1, 1984   Volume 65, Issue 8 601-605 
Duncan SG, Reed SM.In horses with large bowel disease, those with circulating endotoxins but no evidence of altered hemostasis had a good prognosis for survival. Those with circulating endotoxins and evidence of altered hemostasis (fibrin degradation products) had a poor prognosis. Portal vein infusion of endotoxins over 24 hours caused hoof discomfort, evidenced by shifting of weight and standing with all 4 feet together, and a decreased hoof temperature. Clinical signs appeared within 30 minutes of initiation of infusion and subsided within 4 hours despite continued infusion. Long-term heparin therapy results ...
Haemostatic mechanisms of the newborn foal: reduced platelet responsiveness.
Equine veterinary journal    July 1, 1984   Volume 16, Issue 4 353-356 doi: 10.1111/j.2042-3306.1984.tb01941.x
Clemmons RM, Dorsey-Lee MR, Gorman NT, Sturtevant FC.Whole blood platelet counts, coagulation profiles and in vitro platelet function tests were monitored in newborn foals during the first week of life. Platelet counts, mean platelet volumes and thrombin-induced malondialdehyde production were not different from adult mares. Prothrombin and partial thromboplastin times were slightly, but not significantly, longer for neonatal blood samples than for mare samples. Platelet aggregation responses to serotonin, arachidonic acid or adrenaline did not change during the study. On the other hand, adenosine diphosphate-induced aggregation and collagen-ind...
Measurement of plasma antithrombin III activity in healthy horses.
American journal of veterinary research    February 1, 1984   Volume 45, Issue 2 351-353 
Stephens KA, Morcom E, Hood DM.A fluorometric assay was used to determine plasma antithrombin III (AT III) activities in 15 healthy adult horses. Nearly all plasma samples had an initial value of greater than 100% thrombin inhibited, so a 1:1 dilution of the prepared samples was performed. Following dilution, the mean value of the animals was 59.17 +/- 7.4% thrombin inhibited. Mares had significantly greater AT III activity than did geldings (P less than 0.01). The results of this study indicate the horse has more AT III activity than did other domestic species in which AT III activity has been reported.
Reduction of the red blood cell mass of horses: toxic effect of heparin anticoagulant therapy.
American journal of veterinary research    December 1, 1983   Volume 44, Issue 12 2271-2276 
Duncan SG, Meyers KM, Reed SM.This study was designed to test the efficacy of heparin anticoagulant therapy in the horse and its effect on the formed elements of blood. Nine clinically normal, nontraumatized adult horses were subjected to 4 different heparin maintenance regimens (dosages of 320, 240, 160, and 40 U/kg of body weight). Porcine intestinal mucosa heparin (20,000 U/ml) was injected subcutaneously every 12 hours for 96 hours (total 9 times). A loading dose of one-third the maintenance dose was given IV just before the first heparin injection. Three control horses were given an equivalent volume of 0.9% saline so...
Disseminated intravascular coagulation in experimental intestinal strangulation obstruction in ponies.
American journal of veterinary research    November 1, 1983   Volume 44, Issue 11 2115-2122 
Pablo LS, Purohit RC, Teer PA, Newton JC, Hammond LS.Total strangulation obstruction of the caudal part of the jejunum was induced in 3 groups (each of 3 ponies) for 2, 4, and 6 hours. Coagulation tests which included blood platelet counts, prothrombin time, activated partial thromboplastin time, activated coagulation time, plasma fibrinogen level, and fibrin/fibrinogen degradation products assay were performed at specified time intervals for 1 week or until death of the experimental ponies. Another 3 ponies (sham-operated) were similarly treated, except that intestinal strangulation obstruction (ISO) was not induced. Necropsy was done on ponies...
Monoclonal gammopathy in a horse with defective hemostasis.
Veterinary pathology    September 1, 1983   Volume 20, Issue 5 643-647 doi: 10.1177/030098588302000520
Jacobs RM, Kociba GJ, Ruoff WW.No abstract available
Comparative effects of phenylbutazone, naproxen and flunixin meglumine on equine platelet aggregation and platelet factor 3 availability in vitro.
Canadian journal of comparative medicine : Revue canadienne de medecine comparee    April 1, 1983   Volume 47, Issue 2 172-179 
Johnstone IB.Nonsteroidal anti-inflammatory drugs are commonly used in the treatment of inflammatory conditions, and have potential value in the treatment of thrombotic disease in the horse. This study compares the potency of three nonsteroidal anti-inflammatory drugs phenylbutazone, naproxen (equiproxen) and flunixin meglumine (banamine) with respect to their effects on equine platelets. Two functional responses of horse platelets were evaluated in vitro: their ability to aggregate and their ability to make available platelet factor 3 procoagulant activity. Flunixin at a concentration of 10(-6) M signific...
Haemophilia A in a 3-year-old thoroughbred horse.
Australian veterinary journal    February 1, 1983   Volume 60, Issue 2 63-64 doi: 10.1111/j.1751-0813.1983.tb05869.x
Mills JN, Bolton JR.No abstract available
Circulating endotoxin-like substance(s) and altered hemostasis in horses with gastrointestinal disorders: an interim report.
American journal of veterinary research    December 1, 1982   Volume 43, Issue 12 2233-2238 
Meyers K, Reed S, Keck M, Clem M, Bayly W.Twenty-three horses with clinical signs of gastrointestinal disease were evaluated once or serially during the course of the disease for the presence or absence of circulating endotoxin-like substances (ET+ or ET-) and whether the horses were negative, positive, or very positive for serum fibrin/fibrinogen degradation products (FDP-, FDP+, or FDP++). In addition, platelet count, activated partial thromboplastin time (APTT), and 1-stage prothrombin time (OSPT) were measured. When examined initially, 5 horses were ET-/FDP-, 8 were ET-/FDP+, 7 were ET+/FDP-, 3 were ET+/FDP+, and none was ET+/FDP+...
Coagulation studies f plasmas from healthy domesticated animals and persons.
American journal of veterinary research    December 1, 1981   Volume 42, Issue 12 2170-2177 
Greene CE, Tsang VC, Prestwood AK, Meriwether EA.Optimal reaction conditions for the activated partial thromboplastin time (APTT), 1-stage prothrombin time (PT), and Russell's viper venom time were studied for pooled plasmas of horses, cattle, sheep, goats, swine, dogs, cats, and persons. Changes in CaCl2 and NaCl concentrations had significant effects on the APTT and PT reactions. The APTT was more sensitive than the PT to changes in CaCl2 concentration. The CaCl2 concentration recommended by the manufacturer for the APTT was suboptimal for some of plasmas of domesticated animals in ths study. Infusorial earth (Celite, activator) concentrat...
[Anticoagulant therapy in the horse (author’s transl)].
DTW. Deutsche tierarztliche Wochenschrift    August 5, 1981   Volume 88, Issue 8 336-340 
Gerhards H.No abstract available
Effect of oral administration of acetylsalicylic acid on haemostasis in the horse.
Equine veterinary journal    July 1, 1981   Volume 13, Issue 3 205-206 doi: 10.1111/j.2042-3306.1981.tb03491.x
Trujillo O, Rios A, Maldonado R, Rudolph W.No abstract available
[Immunologic response of horses to hemostimulation].
Zhurnal mikrobiologii, epidemiologii i immunobiologii    April 1, 1981   Issue 4 104 
Klemparskaia NN, Tiurin EA, Ivanov AA, Khazina EKh, Raĭkher LI.No abstract available
Effect of aspirin on haemostasis in the horse.
Research in veterinary science    March 1, 1981   Volume 30, Issue 2 241-242 
Judson DG, Barton M.No abstract available
Transport of plasma for prothrombin time testing in monitoring warfarin therapy in the horse.
Journal of the American Veterinary Medical Association    February 1, 1981   Volume 178, Issue 3 306 
Wagner AE.No abstract available
Fibrinolytic activity without fibrinogenolysis during long-distance racing in horses.
Journal of applied physiology: respiratory, environmental and exercise physiology    February 1, 1981   Volume 50, Issue 2 245-249 doi: 10.1152/jappl.1981.50.2.245
Ferguson EW, Bernier LL, Shaughness GP, Boucher JH.Fourteen horses were studied during a 157-km endurance ride. Two humans who ran the 157 km were also evaluated at the finish. Fibrin monomer samples were examined by two-dimensional gel electrophoresis and sodium dodecyl sulfate polyacrylamide gel electrophoresis. Two major species of horse Beta-chain with higher molecular weights and different isoelectric mobilities than human beta-chain were observed. Horse alpha-chains had higher molecular weights than human alpha-chains but similar alpha-chain heterogeneities. Mean euglobulin lysis time (ELT) in the horses was accelerated to similar levels...
Nonenzymic control of prothrombin activation.
Annals of the New York Academy of Sciences    January 1, 1981   Volume 370 336-347 doi: 10.1111/j.1749-6632.1981.tb29746.x
Miller KD.No abstract available
Warfarin anticoagulation in the horse.
Journal of the American Veterinary Medical Association    December 1, 1980   Volume 177, Issue 11 1146-1151 
Scott EA, Byars TD, Lamar AM.The hematologic and clinical effects of anticoagulation with warfarin were documented in 4 horses. All of the animals had thrombophlebitis (external jugular vein). Measures of coagulation were monitored, with a prothrombin time of 1.5 to 2.5 x base-line value being used as the effective range of anticoagulation. Recanalization was achieved in 2 of 4 cases. Hemorrhage, both subcutaneous and through a surgical incision, was a complication. Vitamin K1, an antidote to warfarin toxicosis, was administered intravenously to reverse anticoagulation and to control hemorrhage.
Hemostasis and bleeding disorders.
Veterinary medicine, small animal clinician : VM, SAC    July 1, 1980   Volume 75, Issue 7 1157-1164 
Coffman J.No abstract available
Warfarin: effects on anticoagulant, hematologic, and blood enzyme values in normal ponies.
American journal of veterinary research    January 1, 1979   Volume 40, Issue 1 142-146 
Scott EA, Sandler GA, Byars TD.No abstract available
Warfarin: effects of intravenous loading doses and vitamin K on warfarin anticoagulation in the pony.
American journal of veterinary research    December 1, 1978   Volume 39, Issue 12 1888-1891 
Scott EA, Sandler GA, Byars TD.No abstract available
Diagnosis and treatment of thrombosis of the posterior aorta or iliac arteries in the horse.
Veterinary medicine, small animal clinician : VM, SAC    February 1, 1978   Volume 73, Issue 2 184 
Moffett FS, Vaden P.No abstract available
Comparative study of blood coagulation tests in the horse and pony.
American journal of veterinary research    February 1, 1978   Volume 39, Issue 2 333-336 
Gentry PA, Woodbury FR, Black WD.The clotting times obtained with different assay procedures for routine coagulation tests were examined for horse and pony samples. The whole blood clotting time test and the activated coagulation test seemed to give similar results when both tests were done at 22 C. The results obtained for the activated partial thromboplastin time assay varied, depending on the commercial reagent used for the test. Consistent results were obtained for the one-stage prothrombin time assay with each reagent used.
The diagnosis, management and treatment of bleeding disorders. Part 2.
Modern veterinary practice    September 1, 1977   Volume 58, Issue 9 756-762 
Dodds WJ.No abstract available
A clotting defect in an Arab colt foal.
Equine veterinary journal    January 1, 1977   Volume 9, Issue 1 1-3 doi: 10.1111/j.2042-3306.1977.tb03959.x
Hinton M, Jones DR, Lewis IM, Thomson PE.A multiple clotting defect in a 3 month old Arab colt foal associated with a deficiency in Factors VIII, IX, and XI is described. No abnormalities in clotting factors were detected in the colt's sire, dam, half-sister and half-brother.
[Follow-up study on the hemostatic effect of the Vasolamin preparation in domestic animals].
Veterinarni medicina    February 1, 1976   Volume 21, Issue 2 119-124 
Balun J, Sutta J, Janda J.In this paper the haemocoagulative effect of the Vasolamin preparation was examined after intravenous application in cattle, sheep, and horses by means of tests. After a laboratory confirmation of the coagulative effect of the tested preparation we used it for the purpose of haemostasis in the clinical practice. After an administration of the preparation faster coagulation of the blood was observed in all examined animals. The setting in of the effect could be observed already after 5 minutes, the maximum effect was recorded between the 15th and 30th minutes after application, and the effect l...
Characterization of human, bovine, and horse antithrombin III.
Biochemistry    January 27, 1976   Volume 15, Issue 2 368-373 doi: 10.1021/bi00647a020
Kurachi K, Schmer G, Hermodson MA, Teller DC, Davie EW.A comparison of the physical-chemical properties of human, bovine, and horse antithrombin III has been made. These three plasma proteins are strong inhibitors of bovine factor Xa and form a 1:1 molar complex with this coagulation enzyme. Human, bovine, and horse antithrombin III are glycoproteins containing hexose, hexosamine, and neuraminic acid. The total carbohydrate was 9, 12, and 16% for human, bovine, and horse antithrombin III, respectively. These proteins have a similar amino acid composition, although some monor variations were noted. Each antithrombin III is composed of a single poly...